Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Maire

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|February 27, 2003
Aminoglycoside nephrotoxicity: modeling, simulation, and controlFlorent Rougier, Daniel Claude, Michel Maurin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 8, 2004
Olefins as steering ligands for homogeneously catalyzed hydrogenationsPascal Maire, Stephan Deblon, Frank Breher, et al.
Journal of Hypertension|February 6, 2003
Sodium intake and blood pressure in healthy individualsMichel Ducher, Jean-Pierre Fauvel, Michel Maurin, et al.
Molecular and Cellular Biology|February 18, 2004
Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancerCharis L Himeda, Jeffrey A Ranish, John C Angello, et al.
Mechanisms of Development|April 5, 2005
Six1 is not involved in limb tendon development, but is expressed in limb connective tissue under Shh regulationMarie-Ange Bonnin, Christine Laclef, Régis Blaise, et al.
Fundamental & Clinical Pharmacology|October 19, 2011
The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case studyLaurent Bourguignon, Michel Ducher, David Matanza, et al.
Development (Cambridge, England)|March 25, 2005
Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryoRaphaelle Grifone, Josiane Demignon, Christophe Houbron, et al.
Therapie|July 10, 2016
[Not Available]Laurent Bourguignon, Sylvain Goutelle, Cécile Gérard, et al.
Therapie|May 26, 2009
[Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight]Laurent Bourguignon, Sylvain Goutelle, Cécile Gérard, et al.
Cell Death and Differentiation|June 24, 2020
SIX1 cooperates with RUNX1 and SMAD4 in cell fate commitment of Müllerian duct epitheliumJumpei Terakawa, Vanida A Serna, Devi M Nair, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|February 27, 2003
Aminoglycoside nephrotoxicity: modeling, simulation, and controlFlorent Rougier, Daniel Claude, Michel Maurin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 8, 2004
Olefins as steering ligands for homogeneously catalyzed hydrogenationsPascal Maire, Stephan Deblon, Frank Breher, et al.
Journal of Hypertension|February 6, 2003
Sodium intake and blood pressure in healthy individualsMichel Ducher, Jean-Pierre Fauvel, Michel Maurin, et al.
Molecular and Cellular Biology|February 18, 2004
Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancerCharis L Himeda, Jeffrey A Ranish, John C Angello, et al.
Mechanisms of Development|April 5, 2005
Six1 is not involved in limb tendon development, but is expressed in limb connective tissue under Shh regulationMarie-Ange Bonnin, Christine Laclef, Régis Blaise, et al.
Fundamental & Clinical Pharmacology|October 19, 2011
The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case studyLaurent Bourguignon, Michel Ducher, David Matanza, et al.
Development (Cambridge, England)|March 25, 2005
Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryoRaphaelle Grifone, Josiane Demignon, Christophe Houbron, et al.
Therapie|July 10, 2016
[Not Available]Laurent Bourguignon, Sylvain Goutelle, Cécile Gérard, et al.
Therapie|May 26, 2009
[Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight]Laurent Bourguignon, Sylvain Goutelle, Cécile Gérard, et al.
Cell Death and Differentiation|June 24, 2020
SIX1 cooperates with RUNX1 and SMAD4 in cell fate commitment of Müllerian duct epitheliumJumpei Terakawa, Vanida A Serna, Devi M Nair, et al.
Pageof 9